OS Therapies Schedules United Kingdom’s Medicines and Healthcare products Regulatory Agency’s (MHRA) Scientific Advice Meeting in the Third Quarter of 2025 for Review of its OST-HER2 Immunotherapy Candidate for Osteosarcoma

OS Therapies Schedules United Kingdom’s Medicines and Healthcare products Regulatory Agency’s (MHRA) Scientific Advice Meeting in the Third Quarter of 2025 for Review of its OST-HER2 Immunotherapy Candidate for Osteosarcoma

NEW YORK, March 11, 2025–(BUSINESS WIRE)–OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies…

Continue Reading
NL Health Services Expands Mental Health and Addictions Navigator Program

NL Health Services Expands Mental Health and Addictions Navigator Program

Newfoundland and Labrador (NL) Health Services is pleased to announce the expansion of the provincial Mental…

Continue Reading
GE HealthCare Completes Acquisition of Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan

GE HealthCare Completes Acquisition of Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan

CHICAGO GE HealthCare Technologies Inc. (GE HealthCare or the Company) (Nasdaq: GEHC) has completed its acquisition…

Continue Reading
LIT unveils M facility to tackle Texas nursing shortage

LIT unveils $37M facility to tackle Texas nursing shortage

A new $37 million healthcare facility at LIT is transforming medical education to combat the local…

Continue Reading
Canada’s health care crisis demands a digital solution

Canada’s health care crisis demands a digital solution

by Policy Options. Originally published on Policy Options March 31, 2025 by Policy Options. Originally published…

Continue Reading
Why GE HealthCare Technologies Stock Fell Today

Why GE HealthCare Technologies Stock Fell Today

Shares in GE HealthCare Technologies (NASDAQ: GEHC) were down 9.5% at 1 p.m. today. The decline…

Continue Reading